Schedule 13G ownership disclosure

DAMORA THERAPEUTICS INC

Common Stock, par value $0.00001 per share · CUSIP: 36322Q206

Event date: 2025-11-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 100,001.00 · Class: 6.3%

  • Point72 Capital Advisors, Inc.

    Shares: 100,001.00 · Class: 6.3%

  • Steven A. Cohen

    Shares: 100,001.00 · Class: 6.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-004918
Form type
SCHEDULE 13G
Filer
Galecto, Inc.
CIK
CIK 1800315
Filed
Nov 13, 2025
Reporting period
Nov 12, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub